Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20250430003Phase 4Completed
Phase 4, randomised, double-blind trial comparing Lidocaine + TIVA with Placebo + TIVA (2 arms). Primary endpoint: Primary recovery outcome. Started May 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20250430003.